Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000537182 | SCV000645295 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-12-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV001662568 | SCV001880525 | likely benign | not specified | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413562 | SCV002680854 | uncertain significance | Inborn genetic diseases | 2019-12-23 | criteria provided, single submitter | clinical testing | The p.D2624Y variant (also known as c.7870G>T), located in coding exon 24 of the SETX gene, results from a G to T substitution at nucleotide position 7870. The aspartic acid at codon 2624 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of juvenile amyotrophic lateral sclerosis 4; however, its contribution to the development of spinocerebellar ataxia with axonal neuropathy 2 is uncertain. |
Gene |
RCV002461309 | SCV002757533 | uncertain significance | not provided | 2022-11-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Mayo Clinic Laboratories, |
RCV002461309 | SCV004225119 | uncertain significance | not provided | 2023-06-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925662 | SCV004742861 | likely benign | SETX-related condition | 2022-08-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |